OBI Pharma receives FDA nod for Phase I study of its cancer drug

Drug Discovery |  News | 0 Comment | 18 Jan, 2018

Taiwan-based biopharma company OBI Pharma announced that it has received the US FDA nod for an investigational new drug (IND) application for a Phase 1 study of a monoclonal antibody cancer...Read more

Forty Seven collaborates with Merck KGaA on a novel combination for ovarian cancer

Drug Discovery |  News | 0 Comment | 16 Jan, 2018

Singapore - Forty Seven, a US based clinical-stage company focused on developing the next generation of transformational immuno-oncology treatments to enable a patient's immune system to de...Read more

FDA approves first treatment for breast cancer with a certain inherited genetic mutation

Drug Discovery |  News | 0 Comment | 15 Jan, 2018

Singapore - The U.S. Food and Drug Administration expanded the approved use of Lynparza (olaparib tablets) to include the treatment of patients with certain types of breast cancer that have...Read more

Telix Pharmaceuticals establishes Japanese Subsidiary, Appoints Key Executives

Drug Discovery |  News | 0 Comment | 15 Jan, 2018

Telix Pharmaceuticals , an Australian biopharmaceutical company focused on the development of diagnostic and therapeutic products based on targeted radiopharmaceuticals or “molecularl...Read more

BerGenBio meets first efficacy endpoint in phase II trial evaluating BGB324

Drug Discovery |  News | 0 Comment | 10 Jan, 2018

A clinical –stage biopharmaceutical company BerGenBio ASA has announced that the first efficacy endpoint has been met in its phase II clinical trial evaluating BGB324 (bemcentinib) wh...Read more

Intec Pharma acknowledged with patent

Drug Discovery |  Regulatory | 0 Comment | 08 Jan, 2018

Intec Pharma is a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology. The company announced that the Canadian ...Read more

Pfizer to launch a new venture fund to invest in neuroscience research projects

Drug Discovery |  News | 0 Comment | 08 Jan, 2018

The U.S. pharmaceutical company, Pfizer has announced that it is abandoning research to find new drugs aimed at treating Alzheimer’s and Parkinson’s disease. The company said t...Read more

Drug for diabetes type 2 shows potential in treating Alzheimer’s

Drug Discovery |  News | 0 Comment | 04 Jan, 2018

According to new research published in the Brain Research Journal, a drug developed for type 2 diabetes could possibly be a boon for patients with Alzheimer’s disease. The "triple ag...Read more

Biocon & Mylan's biosimilar gets Brazilian approval

Drug Discovery |  News | 0 Comment | 29 Dec, 2017

The biosimilar trastuzumab has been approved by ANVISA, the Brazilian regulatory agency. Co-developed by Biocon and Mylan, this is the first biosimilar trastuzumab to be approved in Br...Read more

FDA approves drug to treat dangerously low blood pressure

Drug Discovery |  News | 0 Comment | 27 Dec, 2017

Singapore - The U.S. Food and Drug Administration approved Giapreza (angiotensin II) injection for intravenous infusion to increase blood pressure in adults with septic or other distributiv...Read more

Dr. Reddy's launches Melphalan Hydrochloride for Injection in the U.S. Market

Drug Discovery |  News | 0 Comment | 27 Dec, 2017

Dr. Reddy’s Laboratories Ltd has announced that it has launched Melphalan Hydrochloride for Injection which is a therapeutic equivalent generic version of Alkeran® (melphalan hydr...Read more

CANbridge submits investigational new drug application for cancer treatment

Drug Discovery |  News | 0 Comment | 27 Dec, 2017

CANbridge Life Sciences is a bio-pharmaceutical company accelerating development and commercialization of specialty healthcare products for serious and critical medical conditions in China ...Read more

Otsuka collaborates with X-Chem for new drug compounds

Drug Discovery |  News | 0 Comment | 26 Dec, 2017

US based X-Chem, Inc. and Otsuka Pharmaceutical Co., Ltd., a subsidiary of Otsuka Holdings Co., Ltd. headquartered in Tokyo, Japan, have signed a collaborative research agreement to advance...Read more

Adaptive Phase II Study of BAN2401 in Early Alzheimer’s Disease Continues toward 18-Month Endpoint

Drug Discovery |  News | 0 Comment | 22 Dec, 2017

Eisai Co., Ltd. and Biogen Inc. has announced that an Independent Data Monitoring Committee has determined that BAN2401, an anti-amyloid beta protofibril antibody, did not meet the criteria...Read more

Confo Therapeutics enters into collaboration with Roche

Drug Discovery |  News | 0 Comment | 20 Dec, 2017

Drug Discovery company, Confo Therapeutics has announced that it has entered into a research collaboration and license agreement with Roche for the discovery, development and commercialisat...Read more

Researchers show patients' own immune cells can fight deadly cancers

Drug Discovery |  News | 0 Comment | 15 Dec, 2017

Singapore - Scientists have taken a significant step forward in efforts to harness our own white blood cells to fight deadly cancers. A pilot study, funded by Montefiore Einstein Cente...Read more

Bioelectronic medicine to treat lupus

Drug Discovery |  News | 0 Comment | 15 Dec, 2017

Singapore - Researchers at Northwell Health's Feinstein Institute for Medical Research are conducting a clinical trial to evaluate the efficacy of bioelectronic medicine to treat ...Read more

Sirenas receives $1.68 M research grant to accelerate ATLANTIS

Drug Discovery |  News | 0 Comment | 13 Dec, 2017

Singapore – Sirenas, a biotechnology company harnessing computational approaches to discover therapeutics derived from nature's chemistry, announced that it has received a new grant f...Read more